This site is intended for Healthcare Professionals only

Incorrect username and/or password, please try again or click to reset.

Imigran Injection/Subject - syringes may have needles protruding from the needle shield

2014-12-17 15:02:24 (11 year(s) ago)

Summary

(GlaxoSmithKline UK) Remaining stocks of the affected batch should be quarantined and returned to the original supplier for credit – class 2 action within 48 hours. (EL (13)A/26)

Read full MHRA article

Respond to this alert

Sign up for your FREE ticket to see PharmData at the Pharmacy Show to see our latest products and features demonstrated live!